Natixis Advisors, L.P. Amneal Pharmaceuticals, Inc. Transaction History

Natixis Advisors, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$6.44 - $14.29 $112,532 - $249,703	-17,474 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.87 - $14.84 $207,416 - $259,314	17,474 New	17,474 $248,000
Q4 2018 Feb 13, 2019	SELL	$13.09 - $21.49 $288,267 - $473,252	-22,022 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$16.4 - $24.27 $17,941 - $26,551	1,094 Added 5.23%	22,022 $489,000
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $291,945 - $422,745	20,928 New	20,928 $0

184

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.